Implanté à Bruxelles, Interface Europe est un cabinet conseil en recherche de financement, stratégie, montage et management de projets en recherche et innovation.
http://www.interfaceurope.eu/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Saturday
LOAD TIME
16x16
32x32
64x64
128x128
160x160
192x192
256x256
PAGES IN
THIS WEBSITE
2
SSL
EXTERNAL LINKS
21
SITE IP
94.46.255.62
LOAD TIME
0 sec
SCORE
6.2
Financement et management de recherche et innovation | Interface Europe | interfaceurope.eu Reviews
https://interfaceurope.eu
Implanté à Bruxelles, Interface Europe est un cabinet conseil en recherche de financement, stratégie, montage et management de projets en recherche et innovation.
Le Blog des Projets Européens - Le blog d'interface europe
Le Blog des Projets Européens. Le blog d'interface europe. Type and hit enter to search. Bridge the gap with Bio-Based Industries JU. Admin-Europe: Are you writing a project proposal and just interested in preparing the scientific part of the proposal? When Nanotech and Advanced materials are combined to drive competitiveness and sustainability…. H2020 Funding opportunities for Design-Driven Innovation. L’impact dans les projets européens : kezako? Le Blog des Projets Européens. The dutch , shorter and.
interfaceurope.eu
Conseil en financement européen de la recherche et l’innovation (R&I)
http://www.interfaceurope.eu/index.php
Webinars sur les programmes européens de financement de la recherche et de l’innovation. Nos services : financement européen et management de la recherche et de l’innovation (R&I). Améliorer vos chances de succès sur Horizon 2020. Le Blog des Projets Européens. L'actualité des programmes européens de financement de la R&I par nos experts. Maximiser vos chances de succès, minimiser les risques! Energie, Transport, Environnement, Santé, TIC. Les programmes de financement et leurs objectifs. Détection des s...
Home
http://www.interfaceurope.eu/index.php?page=home
Webinars on the European funding programs of Research and Innovation. Improve your chances of success under Horizon 2020. Our blog offers analysis on the European funding programs of R&I. Maximise the impact of your projects by aligning them with European priorities! Energy, Transport, Environment, Health, ICT. Funding Programs and their objectives. The values of an Association, the strengths of a Company. Interface Europe : Consulting in European funding Learn More. For which European funding? Our exper...
TOTAL PAGES IN THIS WEBSITE
2
SAFE-T - Press
http://www.imi-safe-t.eu/htdocs/biomarker/drug-induced-injury/press
PSTC and SAFE-T press release. SAFE-T project is supported by the European Community under the Innovative Medicines Initiative (IMI) Programme. This website does not represent the opinion of the European Community or the IMI Joint Undertaking, and the European Community is not responsible for the data published here - Website provided by Interface Europe.
SAFE-T - Collaborations
http://www.imi-safe-t.eu/htdocs/biomarker/drug-induced-injury/collaborations
SAFE-T seeks collaboration with similar initiatives to establish strong links and networks in the field of biomarkers research and thus improve further the quality of research results. At the moment the collaboration agreements are in the process of negotiation or signed with:. Critical Path Institute’s PSTC consortium. To contribute with additional cases of patient population having liver injury and provide expertise in DILI epidemiology. Málaga University (UMA). SAFE-T project is supported by the Europ...
SAFE-T - Upcoming Conferences
http://www.imi-safe-t.eu/htdocs/biomarker/drug-induced-injury/upcoming-conferences
The conferences where SAFE-T is intending to present in the near future:. Biomarkers in Drug Discovery and Development 2012 meeting. Sept 11th, 2012 - Berlin. October 7-8, 2012 - Brussels. American Society of Nephrology’s Kidney Week. November 2nd, 2012 - San Diego.
SAFE-T - SAFE-T Consortium meeting in Stevenage (UK), 29-31 October 2013
http://www.imi-safe-t.eu/htdocs/feeds/view/10
SAFE-T Consortium meeting in Stevenage (UK), 29-31 October 2013. The annual SAFE T face to face meeting is taking place this year in UK. The meeting will give opportunity to share the project progress since F2F in Stevenage (UK), to discuss budget situation and project extension, and to present project current status and next steps. The F2F meeting will be hosted by GSK. GSK (GlaxoSmithKline) is a global pharmaceutical company based in the UK, but with R&D facilities in both the UK and the US.
SAFE-T - Objectives
http://www.imi-safe-t.eu/htdocs/biomarker/drug-induced-injury/objectives
The general objective of the project is to qualify new specific and sensitive safety biomarkers for drug-induced kidney, liver and vascular injury to improve safety assessment during drug development. In particular, the purpose of SAFE-T work is to:. Evaluate the utility of safety biomarkers for monitoring organ safety in humans. Develop assays and devices for clinical application of safety biomarkers.
SAFE-T - Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) collaborate on development of important new drug safety tests
http://www.imi-safe-t.eu/htdocs/feeds/view/11
Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) collaborate on development of important new drug safety tests. Back to news list. SAFE-T project is supported by the European Community under the Innovative Medicines Initiative (IMI) Programme. This website does not represent the opinion of the European Community or the IMI Joint Undertaking, and the European Community is not responsible for the data published here - Website provided by Interface Europe.
SAFE-T - The Safer And Faster Evidence-based Translation consortium
http://www.imi-safe-t.eu/htdocs
Ldquo;SAFE-T Consortium is a unique partnership of the European Pharmaceutical Industry, Academics and Small and Medium Enterprises who are working together to qualify translational safety biomarkers for drug-induced kidney, liver and vascular injury to enable potential new medicines to be evaluated more quickly and safely in patients.”. Critical Path Institute (C-Path) and Innovative Medicines Initiative (IMI) collaborate on development of important new drug safety tests. Total Budget of 35.7 million.
Get European funding with Admin Europe, focus on science
http://blog.interfaceurope.eu/admin-europe-service-to-get-european-funding-under-h2020
Type and hit enter to search. HORIZON 2020 Health: getting ready for the upcoming 2016-2017 calls. L’impact dans les projets européens : kezako? H2020: Overall challenges and principles underlying the Health societal challenge. Scope and Impact of Horizon 2020 SME Instrument-06: Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well (SMEInst-06-2016-2017). Horizon 2020 SME Instrument: Supporting innovative SMEs in the healthcare biotechnology sector (SMEInst-05-2016-2017).
SAFE-T - Publications
http://www.imi-safe-t.eu/htdocs/biomarker/drug-induced-injury/publications
Plasma profiling reveals novel biomarkers for drug-induced liver injury in humans. 13th Human Proteome Organization World Congress, Madrid, 5-8 October 2014. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology 2014 Jul;147(1):109-118. PMID: 24704526. Qualification of clinical safety biomarkers Lessons learned from the IMI SAFE-T consortium. Exploratory Clinical Development World, London (UK), 3-5 June 2014. Society of T...
TOTAL LINKS TO THIS WEBSITE
21
Home - Interface Uganda
Registered Charity No. 1091419. Call Us On: 01392 860732. Sarah Hodges, Andrew Hodges and George Galliwango. Interface Uganda is a registered UK charity established in 2001, which aims to provide essential reconstructive surgery and to equip and train local specialists in Uganda and the surrounding areas. Interface Uganda is a registered UK charity established in 2001, which aims to provide essential reconstructive surgery and to equip and train local specialists in Uganda and the surrounding areas.
ДОБРО ПОЖАЛОВАТЬ
Use these links to ‘jump’ to different parts of this page or different pages on the Interface site. You can use these links at any time. Jump to the site navigation – a list of links to the main sections of the site (Access key ‘n’). Jump to the content of this page (Access key ‘c’). Return to the home page (Access key ‘1’). Read our privacy policy (Access key ‘8’). Return to these link at any time (Access key ‘0’). Это нечто большее, чем набор взаимосвязей. Это цикл прекрасных идей. Interface применяет ...
::Portfolio:: Christopher J. R. Clayden
interfaceurope.com - This website is for sale! - interface u rope Resources and Information.
The domain interfaceurope.com. May be for sale by its owner! The domain interfaceurope.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
Financement et management de recherche et innovation | Interface Europe
Améliorer vos chances de succès sur Horizon 2020. Le Blog des Projets Européens. L'actualité des programmes européens de financement de la R&I par nos experts. Maximiser vos chances de succès, minimiser les risques! Energie, Transport, Environnement, Santé, TIC. Les programmes de financement et leurs objectifs. Les valeurs d'une Association, les forces d'une Entreprise. Interface Europe : Conseil en financement et management de la recherche et de l’innovation En savoir plus ›. Notre cabinet de conseil.
Interfaceurs
Chers internautes, cette rubrique vous permet de voyager, devant votre ordinateur, et surtout de deviner où sont pris les clichés. Histoire de mémoriser un lieu, une origine? Histoire d'échanger. Histoire de faire partager. Christian Prost. Samedi 8 juin 2013. Fabrique de l'image N°1. Mais qu'est-il donc arrivé aux arbres de cette belle photo de Christian Prost? Quel sens possibles d'une telle transformation? Fabrique de l'image N°2. Décidemment ils exagèrent à Saint-Apo! Fabrique de l'image N°3. Si vous...
interfaceus.com - This website is for sale! - interface us Resources and Information.
The domain interfaceus.com. May be for sale by its owner! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.
Catheter Manufacturing :: Balloon Catheters Manufacturer, Medical Balloon Design, Prototype, and Production :: Interface Catheter Solutions
Balloon Design and Development. Balloon Catheter Manufacturing Equipment. Extrusion capabilities specifically designed for balloon production. Precise monitoring and control of the extrusion process provides balloon tubing with consistent and controllable performance characteristics for successful high-yield medical balloon manufacturing. Balloon Design and Development. Interface has created more than 2,300 balloon designs and provides balloon development and contract manufacturing. Improve balloon yield...
SOCIAL ENGAGEMENT